I recently joined a new law firm as a partner and established its Life Sciences Practice. Spencer Fane provides a much bigger platform for my clients including a full range of legal services including venture finance, strategic business planning, and patent litigation services. The firm also has the financial resources to work with new companies that are frequently undercapitalized. Spencer Fane is committed to supporting the commercialization model I began developing in the year 2000 and fully implemented in 2006 and we will continue to serve clients in this entrepreneurial capacity. It's a great opportunity that I'm very excited about, even though it brings Biotactica to an end.

Valerie Tomlinson, with whom I have worked for six years, joined me and will continue to handle international patent matters as our IP paralegal. The Life Sciences Practice's first hire is Dr. Gale Starkey, a medicinal chemist who has a decade of experience as a university professor, inventor and organic chemist in industry. Gale and I go back several years when he was with a St. Louis start-up, Apath LLC, and we worked together drafting patent applications for his anti-viral compounds. We've been embraced by a tight-knit team including Kyle Elliott, chair of the firm's Intellectual Property & Technology practice, Glenn Robbins, Scott Kimsey, and Mike Thorne, among many other members of this incredible law firm.

Now that I am settled, I plan to focus more more attention on the BioCommercialization Blog.  Until then, cheers!